Navigation Links
Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
Date:3/13/2008

to create a drug development company with a robust pipeline of monoclonal antibody candidates in oncology, proprietary antibody discovery platforms, biopharmaceutical manufacturing capabilities and sufficient cash to fund operations at least through the end of 2009. The merger is expected to close in the first half of 2008.


'/>"/>
SOURCE Raven biotechnologies, inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
2. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
3. Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
4. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
5. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
6. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
7. Inclinix Announces New Patent for Expert System Platform
8. Genzyme Announces Presentation of New Positive Data on Carticel(R)
9. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
10. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014 Adaptive Biotechnologies, ... Sequencing (NGS) to profile the adaptive immune system, is ... as Chief Commercial Officer (CCO). The addition of ... recent key hires from leading global healthcare companies, including ... (General Counsel) from Genomic Health and Sean ...
(Date:9/16/2014)... Sept. 16, 2014 EHE International, the recognized leader ... physician network, today announced that David Abrams M.D . ... an EHE-certified preventive care center. Through David Abrams M.D ... region now have greater access to EHE,s preventive care programs ... is proud to add Dr. Abrams M.D. to its growing ...
(Date:9/16/2014)... , Sept. 16, 2014 QPID Health , ... to new headquarters in Boston and ... headquarters will be at 175 Franklin Street in ... marketing teams. QPID Health,s new Southern California ... Carlsbad.  The expansion will help meet the demands of customers ...
Breaking Medicine Technology:Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 2Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 3EHE International Certifies David Abrams M.D. as Its Newest Partner 2QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2
... 3, 2010 Cardiogenesis Corporation (OTCQB: CGCP), a leading ... diffuse coronary artery disease, today reported financial results for ... 30, 2010. Revenue for the third quarter ... year third quarter revenue of $2,134,000.  Gross margin was ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), ... that it has expanded its Medisystems® in-center product portfolio ... to the terms of the strategic Agreement with Vasc-Alert ... in the United States.   Vasc-Alert, a ...
Cached Medicine Technology:Cardiogenesis Reports Third Quarter 2010 Results 2Cardiogenesis Reports Third Quarter 2010 Results 3Cardiogenesis Reports Third Quarter 2010 Results 4Cardiogenesis Reports Third Quarter 2010 Results 5Cardiogenesis Reports Third Quarter 2010 Results 6NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™ 2NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™ 3
(Date:9/16/2014)... Las Vegas, NV (PRWEB) September 17, 2014 ... Lewis that shows dog owners the true poisonous ingredients in ... homemade dog food recipes has caught the attention of Shane ... their dogs are just as much of a family member ... tragic when their dog dies earlier than it should due ...
(Date:9/16/2014)... the UK report a poorer experience of care during ... on their care, suggests a new study published today ... Obstetrics and Gynaecology ( BJOG ). , Differences ... demonstrated in many areas and have provided the focus ... observed inequalities. , The Oxford University study, funded by ...
(Date:9/16/2014)... Keep that sexy decolletage as you age, and frame ... Face Whisperer Neck & Decollete Cream is made ... Sublime Beauty®. "It contains rich ingredients to care for the ... A special ingredient is Argireline, known as the natural botox, ... comes in an airless pump bottle, and is part of ...
(Date:9/16/2014)... UT (PRWEB) September 16, 2014 ... Solution, published new information on transitioning employees to ... Benefits, with the Affordable Care Act (ACA) in ... will be steering some or all of their ... no surprise. With guaranteed issue plans, coverage for ...
(Date:9/16/2014)... 17, 2014 UWDress.com, the well-known wedding ... elegant evening wear assortment online. Additionally, the firm ... people can access big discounts now, up to 62 ... evening gowns are charming; it has won a lot ... evening outfits, it is also providing big savings on ...
Breaking Medicine News(10 mins):Health News:Dog Food Secrets: Review Exposes Andrew Lewis’ Guide to Happier, Healthier Dogs with Homemade Dog Food 2Health News:A greater focus on socially disadvantaged women is needed to improve maternity care in England 2Health News:15% Off Face Whisperer® Neck & Decollete Cream Now from Sublime Beauty; Care For This Delicate Skin That Shows Age Quickly 2Health News:Zane Benefits Publishes New Information on Transitioning Employees to Individual Health Insurance 2Health News:New Elegant Evening Wear Assortment Released By UWDress.com 2
... as likely to miscarry during the first three weeks of ... study is the first of it’s kind to have established ... at an early stage. ,Cortisol is a hormone ... this hormone serve as a reliable stress indicator. Nearly 61 ...
... officially confirmed the cause of three dead swans found in Bulgaria ... It has said that it has confirmed it from the country's ... Lake in the Varna region and at Burgas beach have tested ... necessary steps by completely cordoning it off from the public. An ...
... is the second-biggest killer of women in UK. The recent reports ... they take a genetic breast cancer test caused a lot of ... 40,000 diagnoses are done each year and 13,000 deaths are expected. ... would not ask for women to take genetic breast cancer tests. ...
... spurt of fungal infections in contact lens wearers and this ... seven reported last month. //This takes the overall cases since ... infections and the Singapore National Eye Centre (SNEC) has treated ... and Lomb's (B&L) ReNu with MoistureLoc solution and the Health ...
... euthanasia campaigner Dr Philip Nitschke does not possess a license ... informs participants of their legal rights about ending their lives., ... registered as a doctor to carry out his euthanasia workshops. ... he needs a licence. He faces a criminal conviction if ...
... to a study by Emory University researcher Chensheng "Alex" ... two common pesticides used in U.S. agricultural production.'// ... of children with organic food items. The result was ... ,As stated by Dr. Lu, "The ...
Cached Medicine News:Health News:Early Miscarriage Common In Women Under Stress 2Health News:Health insurance in the future would depend on genetic test results 2
XL STABI Hydrophilic Acrylic Lens....
TRIPODE Hydrophilic Acrylic Lens....
Biocryl™ Acrylic Foldable Lens....
The STAAR ELASTIMIDE lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
Medicine Products: